Cargando…
Pretreatment of UC-MSCs with IFN-α2 improves treatment of liver fibrosis by recruiting neutrophils
BACKGROUND: The use of umbilical cord mesenchymal stem cells (UC-MSCs) is a burgeoning method for the treatment of liver cirrhosis. However, the secretory phenotype and regulatory ability of UC-MSCs are easily affected by their microenvironment. Ensuring a specific microenvironment to enhance the UC...
Autores principales: | Xie, Ye, Yao, Jia, Yan, Mengchao, Lin, Yan, Wei, Jiayun, Wang, Haiping, Mao, Yongcui, Liu, Pinyan, Li, Xun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10656886/ https://www.ncbi.nlm.nih.gov/pubmed/37980535 http://dx.doi.org/10.1186/s12967-023-04732-0 |
Ejemplares similares
-
Stem cells for treatment of liver fibrosis/cirrhosis: clinical progress and therapeutic potential
por: Liu, Pinyan, et al.
Publicado: (2022) -
Heterogeneous matrix stiffness regulates the cancer stem-like cell phenotype in hepatocellular carcinoma
por: Wei, Jiayun, et al.
Publicado: (2022) -
HSD11B1 is upregulated synergistically by IFNγ and TNFα and mediates TSG-6 expression in human UC-MSCs
por: Huang, Peiqing, et al.
Publicado: (2020) -
The high level of IL-1β in the serum of ACLF patients induces increased IL-8 expression in hUC-MSCs and reduces the efficacy of hUC-MSCs in liver failure
por: Wang, Yong-Hong, et al.
Publicado: (2023) -
Cell Therapy for Androgenetic Alopecia: Elixir or Trick?
por: Mao, Yongcui, et al.
Publicado: (2023)